Literature DB >> 10753860

Binding of liganded vitamin D receptor to the vitamin D receptor interacting protein coactivator complex induces interaction with RNA polymerase II holoenzyme.

N Chiba1, Z Suldan, L P Freedman, J D Parvin.   

Abstract

Because the vitamin D receptor interacting protein (DRIP) coactivator complex shares components with the RNA polymerase II (Pol II) holoenzyme complex, we tested whether the two protein complexes associate in cellular extracts. On initial purification steps, the DRIP complex copurified with the Pol II holoenzyme. Pol II was found to bind to the vitamin D receptor in a ligand-dependent fashion when either nuclear extracts or partially purified preparations were used as sources of DRIP and Pol II holoenzyme. A subpopulation of holoenzyme complexes bound to the receptor because BRCA1, which associates with the Pol II holoenzyme, did not associate with the liganded receptor, and only in certain of the holoenzyme- and DRIP-containing fractions did Pol II bind to the liganded receptor. Immunoprecipitation experiments revealed that the DRIP complex was not pre-associated with the Pol II holoenzyme, but the interaction between these two complexes was induced only in the presence of receptor and ligand. These data support a model in which the activation of transcription by hormone-bound receptor requires binding to the DRIP coactivator, and this induced ternary complex can then bind to the Pol II holoenzyme to activate transcription.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10753860     DOI: 10.1074/jbc.275.15.10719

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Discrete roles for peroxisome proliferator-activated receptor gamma and retinoid X receptor in recruiting nuclear receptor coactivators.

Authors:  W Yang; C Rachez; L P Freedman
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  Hypovitaminosis D as predisposing factor for atrophic type A gastritis: a case-control study and review of the literature on the interaction of Vitamin D with the immune system.

Authors:  Antonio Antico; Renato Tozzoli; Davide Giavarina; Elio Tonutti; Nicola Bizzaro
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

3.  The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain.

Authors:  R M Nissen; K R Yamamoto
Journal:  Genes Dev       Date:  2000-09-15       Impact factor: 11.361

4.  Characterization of mediator complexes from HeLa cell nuclear extract.

Authors:  G Wang; G T Cantin; J L Stevens; A J Berk
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

5.  Synergy between estrogen receptor alpha activation functions AF1 and AF2 mediated by transcription intermediary factor TIF2.

Authors:  A Benecke; P Chambon; H Gronemeyer
Journal:  EMBO Rep       Date:  2000-08       Impact factor: 8.807

6.  An enhancer 20 kilobases upstream of the human receptor activator of nuclear factor-kappaB ligand gene mediates dominant activation by 1,25-dihydroxyvitamin D3.

Authors:  Robert D Nerenz; Melissa L Martowicz; J Wesley Pike
Journal:  Mol Endocrinol       Date:  2008-01-17

7.  Exon-level transcriptome profiling in murine breast cancer reveals splicing changes specific to tumors with different metastatic abilities.

Authors:  Amandine Bemmo; Christel Dias; April A N Rose; Caterina Russo; Peter Siegel; Jacek Majewski
Journal:  PLoS One       Date:  2010-08-06       Impact factor: 3.240

Review 8.  Pleiotropic Activities of Vitamin D Receptors - Adequate Activation for Multiple Health Outcomes.

Authors:  Jackson W Ryan; Paul H Anderson; Howard A Morris
Journal:  Clin Biochem Rev       Date:  2015-05

9.  The TRAP100 component of the TRAP/Mediator complex is essential in broad transcriptional events and development.

Authors:  Mitsuhiro Ito; Hirotaka J Okano; Robert B Darnell; Robert G Roeder
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

10.  Human CRSP interacts with RNA polymerase II CTD and adopts a specific CTD-bound conformation.

Authors:  Anders M Näär; Dylan J Taatjes; Weiguo Zhai; Eva Nogales; Robert Tjian
Journal:  Genes Dev       Date:  2002-06-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.